Osaka Organic Chemical Industry (4187) Q3 2025 earnings summary

Executive summary

• Net sales for the nine months ended August 31, 2025, rose 12.3% year-over-year to ¥26,699 million, with growth across all business segments.

• Operating profit surged 54.5% year-over-year to ¥4,631 million, driven by higher sales and lower depreciation.

• Ordinary profit increased 57.9% year-over-year to ¥4,844 million, and profit attributable to owners of parent rose 22.1% to ¥3,435 million.

• The medium-term management plan, Progress & Development 2030, was launched, focusing on ESG and global market expansion, including a new North American joint venture.

Financial highlights

• Net sales up ¥2,914 million year-over-year; operating profit up ¥1,633 million; ordinary profit up ¥1,777 million.

• Gross profit increased to ¥8,537 million from ¥6,730 million year-over-year.

• Basic earnings per share for the period were ¥167.63, up from ¥133.00 in the prior year.

• Comprehensive income grew 30.0% year-over-year to ¥3,792 million.

• Progress rates against full-year forecasts: net sales 78.5%, operating profit 92.6%, ordinary profit 93.2%, profit 98.1%.

Outlook and guidance

• Full-year net sales forecast at ¥34,000 million, operating profit at ¥5,000 million, ordinary profit at ¥5,200 million, and profit at ¥3,500 million.

• Full-year net sales forecast is up 4.0% year-over-year, operating profit up 8.5%, and profit attributable to owners of parent down 13.5%.

• Basic earnings per share for the full year are forecast at ¥165.50.

• Dividend forecast for FY2025 is ¥69.00 per share, up from ¥66.00 in FY2024.

• Forward-looking statements caution that actual results may differ due to various risks.